William Blair Predicts Reduced Earnings for Simulations Plus

Simulations Plus, Inc. (NASDAQ:SLP) – Analysts at William Blair reduced their Q2 2026 earnings estimates for Simulations Plus in a research note issued to investors on Friday, April 4th. William Blair analyst M. Smock now expects that the technology company will earn $0.30 per share for the quarter, down from their prior estimate of $0.31. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Simulations Plus’ current full-year earnings is $1.09 per share. William Blair also issued estimates for Simulations Plus’ Q3 2026 earnings at $0.34 EPS and FY2026 earnings at $1.25 EPS.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.06. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business had revenue of $22.43 million for the quarter, compared to the consensus estimate of $21.93 million. During the same quarter in the previous year, the firm earned $0.20 earnings per share. The business’s quarterly revenue was up 22.5% compared to the same quarter last year.

Several other research analysts have also weighed in on the stock. KeyCorp upped their target price on shares of Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. StockNews.com upgraded shares of Simulations Plus from a “sell” rating to a “hold” rating in a research report on Friday. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $49.40.

Simulations Plus Price Performance

Shares of SLP stock opened at $25.68 on Monday. The business’s fifty day moving average price is $30.03 and its 200 day moving average price is $30.27. The firm has a market capitalization of $515.96 million, a PE ratio of 64.20 and a beta of 1.13. Simulations Plus has a 1-year low of $23.01 and a 1-year high of $51.22.

Insider Activity at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total transaction of $678,200.00. Following the sale, the director now directly owns 3,402,584 shares of the company’s stock, valued at $115,381,623.44. This trade represents a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 19.40% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Simulations Plus

Several institutional investors and hedge funds have recently modified their holdings of the company. Quantbot Technologies LP acquired a new stake in Simulations Plus during the third quarter worth approximately $59,000. BNP Paribas Financial Markets lifted its stake in shares of Simulations Plus by 402.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company’s stock worth $1,279,000 after purchasing an additional 32,002 shares during the period. Verition Fund Management LLC boosted its holdings in shares of Simulations Plus by 120.5% during the third quarter. Verition Fund Management LLC now owns 10,365 shares of the technology company’s stock worth $332,000 after purchasing an additional 5,665 shares during the last quarter. State Street Corp grew its position in shares of Simulations Plus by 4.7% in the third quarter. State Street Corp now owns 640,303 shares of the technology company’s stock valued at $20,503,000 after purchasing an additional 28,953 shares during the period. Finally, First National Bank of Omaha increased its stake in Simulations Plus by 56.1% in the third quarter. First National Bank of Omaha now owns 9,704 shares of the technology company’s stock valued at $311,000 after purchasing an additional 3,488 shares during the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.